| Revenue | 2,472a | 3,035a |
| Other income | — | — |
| Share of net profit of joint ventures and associates | 198a | |
| Gain on sale of assets | 60a | |
| Revaluation gain on financial instruments | 5a | 2a |
| Total revenue and other income | 2,735a | 3,037a |
| Development expenses | -1,575a | -1,867a |
| Cost of goods sold interest | -25a | -58a |
| Impairment of inventory and other assets | -82a | |
| Selling and marketing expenses | -32a | -40a |
| Revaluation loss on investment properties | -315a | -816a |
| Share of net losses of joint ventures and associates | | -237a |
| Impairment loss on joint ventures and associates | | -42a |
| Loss on disposal of assets | -4a | -23a |
| Investment property expenses and outgoings | -182a | -192a |
| Depreciation and amortisation expenses | -69a | -75a |
| Employee expenses | -133a | -122a |
| Finance costs | -181a | -197a |
| Revaluation loss on financial instruments | -14a | -49a |
| Other expenses | -93a | -99a |
| Profit/(loss) before income tax | 30a | -780a |
| Income tax (benefit)/expense | -38a | -25a |
| Profit/(loss) from continuing operations attributable to stapled securityholders | 68a | -805a |